Advanced search
Publication Cover
Expert Review of Hematology Volume 7, 2014 - Issue 6
Submit an article Journal homepage
193
Views
16
CrossRef citations to date
0
Altmetric
Perspective

Design of the INHIBIT trial: preventing inhibitors by avoiding ‘danger’, prolonging half-life and promoting tolerance

Margaret V RagniDepartment of Medicine, Division Hematology/Oncology, University of Pittsburgh, 3636 Boulevard of the Allies, Pittsburgh, 15213-4306, PA, USA;Hemophilia Center of Western PA, Pittsburgh, PA, USACorrespondence[email protected]
&
Lynn M MalecHemophilia Center of Western PA, Pittsburgh, PA, USA;Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA
Pages 747-755 | Published online: 05 Nov 2014

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.